Klinikum Landshut AdoeR der Stadt Landshut — Clinical Trial Site

9 Registered trials

5 Currently recruiting

Organisation

Klinikum Landshut AdoeR der Stadt Landshut

Location

Landshut, Germany

Identifier

ORG-100048692

Address

Robert-Koch-Strasse 1, West, 84034, Germany

Departments

Frauenklinik
Klinik für Allgemein-, Viszeral- und Thoraxchirurgie
Klinik für Radioonkologie und Strahlentherapie
Medical Clinic I
Medizinische Klinik I
Medizinische Klinik III
Medizinische Klinik III Onkologie/ Hämatologie
Standort Klinik Landshut-Mitte

Clinical trials at this site (9)

Search interface

A PROSPECTIVE, OPEN-LABEL, MULTICENTER, RANDOMIZED, PHASE 3 TRIAL OF ACALABRUTINIB, OBINUTUZUMAB AND VENETOCLAX (GAVE) COMPARED TO OBINUTUZU… Recruiting

2023-506414-46-00 High risk patients defined as having at least one of th 5 2022-04-22
A trial to learn how well baxdrostat with dapagliflozin works compared to dapagliflozin on clinical outcomes alone and how safe it is in adu… Recruiting

2023-506460-14-00 Chronic kidney disease (CKD) and hypertension. 5 2025-05-07
Pre-Operative Treatment in rEseCTable cOlon canceR (PROTECTOR/FIRE-10; AIO-KRK-0620; IAG-VO-0323) Prospective, randomized, open-label, multi… Recruiting

2023-508076-11-00 Colon cancer staged T3-4 and/or nodal positive by CT an 5 2025-04-01
Study to Assess Change in Disease Activity and Adverse Events of Oral Venetoclax With Intravenous (IV) Obinutuzumab in Adult Participants Wi… Recruiting

2023-504599-10-00 Chronic lymphocytic leukemia recurrent 4 2022-03-29
Post-resection/ ablation chemotherapy in patients with metastatic colorectal cancer (FIRE-9 - PORT / AIO-KRK-0418). Prospective, randomized,… Recruiting

2024-512174-10-00 metastatic colorectal cancer 5 2021-11-11
Individualized Immunotherapy in Early-Stage Unfavorable Classical Hodgkin Lymphoma Ended

2022-500571-32-00 Early-Stage Unfavorable Classical Hodgkin Lymphoma 4 2024-05-15
Sacituzumab Govitecan in primary HER2-negative breast cancer (SASCIA) Ended

2023-510390-33-00 HER2-negative breast cancer patients with high relapse 5 2020-10-23
Zibotentan and Dapagliflozin combination, Evaluated in Liver cirrhosis (ZEAL study) Ended

2023-505405-17-00 Liver cirrhosis with features of portal hypertension. 4 2022-10-07
CIRCULATE Ended

2023-506715-18-00 colon cancer stage II, rectal cancer stage II 5 2019-12-04